4 unknown, 2 terminated, 1 active not recruiting, 1 completed. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Unknown 4, Terminated 2, Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Esophageal Neoplasm: new trials by email Literature Review of Esophageal Neoplasm trials Research Report on Esophageal Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma. Camrelizumab - Esophageal Neoplasm, Immunotherapy | Phase 1 / Phase 2 | Active not recruiting | Fujian Medical University Union Hospital | 25 | 2021-11-10 | 2025-11-19 |
| CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer itraconazole - Esophageal Neoplasm, Esophageal Diseases | Phase 2 | Unknown | Hangzhou Cancer Hospital | 38 | 2020-10-01 | 2020-10-14 |
| Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer Omegaven - Esophageal Neoplasm, Gastric Neoplasm | Phase 2 | Terminated | University Hospitals, Leicester | 21 | 2012-05-01 | 2016-05-26 |
| Definitive Chemoradiotherapy and Cetuximab in the Treatment of Locally Advanced Esophageal Cancer Cetuximab - Esophageal Neoplasm | Phase 2 | Unknown | Gabriella Alexandersson von Döbeln | 51 | 2011-01-01 | 2018-09-21 |
| Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma Docetaxel, Fluorouracil - Esophageal Neoplasm, Chemoradiation | Phase 2 | Unknown | Zhu Yujia | 120 | 2010-10-01 | 2016-11-21 |
| Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) Temozolomide - Colorectal Neoplasm, Head and Neck Neoplasm | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 86 | 2007-01-26 | 2017-06-08 |
| Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer Irinotecan (drug), Taxotere (drug), Radiotherapy (procedure) - Esophageal Cancer, Cancer of the Esophagus | Phase 2 | Completed | University of Alabama at Birmingham | 25 | 2002-01-01 | 2023-05-25 |
| A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer UFT (Tegafur/Uracil) - Esophageal Neoplasm | Phase 2 | Unknown | Edelman, Martin, M.D. | 2005-06-24 |
Esophageal Neoplasms (8) · Esophageal Squamous Cell Carcinoma (2) · Adenocarcinoma Of Esophagus (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Esophageal Diseases (1) · Head and Neck Neoplasms (1) · Stomach Neoplasms (1)
Digestive System Diseases (8) · Digestive System Neoplasms (8) · Gastrointestinal Diseases (8) · Gastrointestinal Neoplasms (8) · Neoplasms (8) · Neoplasms by Site (8) · Esophageal Diseases (7) · Head and Neck Neoplasms (7) · Carcinoma (2) · Carcinoma, Squamous Cell (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Squamous Cell (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1)
Docetaxel (2) · Cetuximab (1) · Cisplatin (1) · Esophagectomy (1) · Fish Oils (1) · Fluorouracil (1) · Irinotecan (1) · Itraconazole (1) · Pharmaceutical Preparations (1) · Radiotherapy (1) · Tegafur (1) · Temozolomide (1) · Uracil (1) · camrelizumab (1) · fish oil triglycerides (1)
Edelman, Martin, M.D. (1) · Fujian Medical University Union Hospital (1) · Gabriella Alexandersson von Döbeln (1) · Hangzhou Cancer Hospital (1) · Merck Sharp & Dohme LLC (1) · University Hospitals, Leicester (1) · University of Alabama at Birmingham (1) · Zhu Yujia (1)
China (3) · United States (2) · United Kingdom (1)
Chun Chen, Dortor (1) · David J Bowrey, MD (1) · James A. Posey, M.D. (1) · Yonghong Hu, MD (1)
PMID 23443801, PMID 27342748, PMID 37700348, PMID 41803866
2008 (1)